You are here

Article info

Article menu
Quality improvement report
Improving compliance with appropriateness of testing for heparin-induced thrombocytopaenia: a quality improvement report

Authors

  • Meric Mericliler Department of Medicine, Saint Elizabeth's Medical Center, Brighton, Massachusetts, USADepartment of Medicine, Tufts University School of Medicine, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Vera Kazakova Department of Medicine, Saint Elizabeth's Medical Center, Brighton, Massachusetts, USADepartment of Medicine, Tufts University School of Medicine, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Diala Nicolas Department of Pharmacy, Saint Elizabeth's Medical Center, Brighton, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Utkarsh H Acharya Medical Oncology, Brigham and Women's Hospital, Boston, Massachusetts, USAHematologic Oncology Treatment Center, Dana-Farber Cancer Institute, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Bertrand L Jaber Department of Medicine, Saint Elizabeth's Medical Center, Brighton, Massachusetts, USADepartment of Medicine, Tufts University School of Medicine, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Bertrand L Jaber; bertrand.jaber{at}steward.org
View Full Text

Citation

Mericliler M, Kazakova V, Nicolas D, et al
Improving compliance with appropriateness of testing for heparin-induced thrombocytopaenia: a quality improvement report
BMJ Open Quality 2022;11:e001746. doi: 10.1136/bmjoq-2021-001746

Publication history

  • Received December 23, 2021
  • Accepted July 3, 2022
  • First published July 12, 2022.
Online issue publication 
November 15, 2022

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.